Alexander disease: Alzheimer disease of the developing brain?

被引:9
作者
Castellani, RJ
Perry, G
Brenner, DS
Smith, MA
机构
[1] Univ Maryland, Dept Pathol, Div Neuropathol, Baltimore, MD 21201 USA
[2] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
关键词
Alexander disease; Alzheimer disease; Rosenthal fibers; oxidative injury;
D O I
10.1097/00002093-199910000-00010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Alexander disease is a leukodystrophy-like neurodegenerative disease that typically presents in infancy or childhood. The disease is essentially a sporadic condition, and there is no known genetic predisposition or metabolic abnormality. The hallmark of the disease is the diffuse accumulation of Rosenthal fibers (RF) throughout the central nervous system. Although an etiological relationship of the RF to disease pathogenesis has been suspected since the initial description of Alexander disease, such a relationship has not been confirmed. We previously identified a number of oxidative posttranslational modifications, including advanced glycation end products and lipid peroxidation adducts, in intimate association with the RF of Alexander disease. Such oxidative protein damage provides a mechanism, through protein crosslinking, for insolubility and accumulation of RE Notably, these findings show a striking parallel with the biochemical features of age-related neurodegenerative diseases such as Alzheimer disease. Therefore, Alexander disease and Alzheimer disease likely share a common pathogenesis, namely oxidative injury as a potential primary process in the etiology and pathogenesis.
引用
收藏
页码:232 / 235
页数:4
相关论文
共 30 条
  • [2] ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES
    BAYNES, JW
    [J]. DIABETES, 1991, 40 (04) : 405 - 412
  • [3] ALEXANDERS DISEASE - A DISEASE OF ASTROCYTES
    BORRETT, D
    BECKER, LE
    [J]. BRAIN, 1985, 108 (JUN) : 367 - 385
  • [4] Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease
    Castellani, R
    Smith, MA
    Richey, PL
    Perry, G
    [J]. BRAIN RESEARCH, 1996, 737 (1-2) : 195 - 200
  • [5] Advanced lipid peroxidation end-products in Alexander's disease
    Castellani, RJ
    Perry, G
    Harris, PLR
    Cohen, ML
    Sayre, LM
    Salomon, RG
    Smith, MA
    [J]. BRAIN RESEARCH, 1998, 787 (01) : 15 - 18
  • [6] Advanced glycation modification of Rosenthal fibers in patients with Alexander disease
    Castellani, RJ
    Perry, G
    Harris, PLR
    Monnier, VM
    Cohen, ML
    Smith, MA
    [J]. NEUROSCIENCE LETTERS, 1997, 231 (02) : 79 - 82
  • [7] TAU, UBIQUITIN, AND ALPHA-BETA-CRYSTALLIN IMMUNOHISTOCHEMISTRY DEFINE THE PRINCIPAL CAUSES OF DEGENERATIVE FRONTOTEMPORAL DEMENTIA
    COOPER, PN
    JACKSON, M
    LENNOX, G
    LOWE, J
    MANN, DMA
    [J]. ARCHIVES OF NEUROLOGY, 1995, 52 (10) : 1011 - 1015
  • [8] CHEMISTRY AND BIOCHEMISTRY OF 4-HYDROXYNONENAL, MALONALDEHYDE AND RELATED ALDEHYDES
    ESTERBAUER, H
    SCHAUR, RJ
    ZOLLNER, H
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1991, 11 (01) : 81 - 128
  • [9] FRIGUET B, 1994, J BIOL CHEM, V269, P21639
  • [10] GOLDMAN JE, 1988, AM J PATHOL, V130, P569